Log in | Register

Time to evaluate biomarkers for use in directing treatment strategies in ARDS patients

Benjamin Coiffard| Laurent Papazian
Editorial
Volume 44, Issue 9 / September , 2018

Pages 1553 - 1555

No abstract available.

References

  1. Papazian L, Calfee CS, Chiumello D, Luyt CE, Meyer NJ, Sekiguchi H, Matthay MA, Meduri GU (2016) Diagnostic workup for ARDS patients. Intensive Care Med 42:674–685
  2. Ware LB, Calfee CS (2016) Biomarkers of ARDS: what’s new? Intensive Care Med 42:797–799
  3. Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G, Fournier M, Marceau G, Dechelotte P, Pereira B, Sapin V, Constantin JM (2015) Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med 192:191–199
    • View reference on publisher's website
    • View reference on PubMed
  4. Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
    • View reference on publisher's website
  5. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA, Network NA (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63:1083–1089
    • View reference on publisher's website
    • View reference on PubMed
  6. Yehya N, Thomas NJ, Meyer NJ, Christie JD, Berg RA, Margulies SS (2016) Circulating markers of endothelial and alveolar epithelial dysfunction are associated with mortality in pediatric acute respiratory distress syndrome. Intensive Care Med 42:1137–1145
  7. Zinter MS, Spicer A, Orwoll BO, Alkhouli M, Dvorak CC, Calfee CS, Matthay MA, Sapru A (2016) Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality. Am J Physiol Lung Cell Mol Physiol 310:L224–231
    • View reference on publisher's website
    • View reference on PubMed
  8. Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, Ware LB (2015) Distinct molecular phenotypes of direct vs. indirect ARDS in single-center and multicenter studies. Chest 147:1539–1548
    • View reference on publisher's website
    • View reference on PubMed
  9. Mrozek S, Jabaudon M, Jaber S, Paugam-Burtz C, Lefrant JY, Rouby JJ, Asehnoune K, Allaouchiche B, Baldesi O, Leone M, Lu Q, Bazin JE, Roszyk L, Sapin V, Futier E, Pereira B, Constantin JM, Azurea Network (2016) Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study. Chest 150:998–1007
    • View reference on publisher's website
    • View reference on PubMed
  10. Jabaudon M, Hamroun N, Roszyk L, Guerin R, Bazin JE, Sapin V, Pereira B, Constantin JM (2015) Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med 41:846–855
  11. Jabaudon M, Futier E, Roszyk L, Sapin V, Pereira B, Constantin JM (2015) Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury. Respirology 20:1131–1138
    • View reference on publisher's website
    • View reference on PubMed
  12. Guervilly C, Lacroix R, Forel JM, Roch A, Camoin-Jau L, Papazian L, Dignat-George F (2011) High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 15:R31
    • View reference on publisher's website
    • View reference on PubMed
  13. Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, Secq V, Farnarier C, Payan MJ, Donati SY, Perrin G, Trousse D, Dizier S, Chiche L, Baumstarck K, Roch A, Papazian L (2015) Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med 41:1–11
  14. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, Network NA (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611–620
    • View reference on publisher's website
    • View reference on PubMed
  15. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS, Network A (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338
    • View reference on PubMed
  16. Jabaudon M, Blondonnet R, Pereira B, Cartin-Ceba R, Lichtenstern C, Mauri T, Determann RM, Drabek T, Hubmayr RD, Gajic O, Uhle F, Coppadoro A, Pesenti A, Schultz MJ, Ranieri MV, Brodska H, Mrozek S, Sapin V, Matthay MA, Constantin JM, Calfee CS (2018) Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data. https://doi.org/10.1007/s00134-018-5327-1

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement